-+ 0.00%
-+ 0.00%
-+ 0.00%

Press Release: Relmada Therapeutics Reports Second Quarter 2025 Financial Results and Announces NDV-01 6-Month Follow-up Safety and Efficacy Data in NMIBC

Dow Jones·08/07/2025 20:05:00

Please log in to view news